NIH funding

The National Institutes of Health Commercial Accelerator Program helps small healthcare and life science companies bring their products to market.

The funding will help the consortium continue creating and updating PGx guidelines, adding drug-gene pairings, and creating electronic tables that can be integrated within EHRs.

The bipartisan bill passed both the House and Senate by large margins and increases the NIH's budget by 5.4 percent over its fiscal 2018 funding level.

The centers will generate genotype and whole-genome sequence data from the samples submitted by participants.

Applicants will be expected to develop the capacity to conduct up to 200,000 genome-wide assays per year and generate high-quality genotyping and genome sequence data.

The six-year, $190 million Somatic Cell Genome Editing program aims to remove barriers that slow the adoption of genome editing for treating patients.